We also noticed a lower age (49.14 ± 1.64 vs. 54.15 ± 1.26 years, p = 0.017) and larger tumor sizes (16.29 ± 4.08 vs. 7.14 ± 1.04 cm3, p = 0.034) in high p53 patients than in low p53 patients, and no statistic difference in gender and invasive behavior (p > 0.05). This evidence concerns the gene TP53 and neoplasm.